Project 3 - Ming Song

项目3-鸣歌

基本信息

  • 批准号:
    10377898
  • 负责人:
  • 金额:
    $ 21.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-06-10 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Project Title: Metabolic effect of fructose in intestine induces gut microbiota dysbiosis Abstract. Emerging evidence has demonstrated that gut microbiota dysbiosis plays a causative role in the development of obesity, type 2 diabetes and NAFLD. Gut “physiologic hypoxia” is key to maintaining a balanced gut microbiota and gut barrier function. Disturbance of gut “physiologic hypoxia”, namely oxygenation, results in gut microbiota dysbiosis. Our preliminary studies have shown that chronic feeding with either fructose or glucose induces gut microbiota dysbiosis in a similar manner in rats and mice. Moreover, both daily gavage and chronic feeding with fructose or glucose results in intestinal oxygenation as shown by HIF-1 alpha reporter (ODD-luc) mice, and this effect is more robust with glucose. Given that fructose is preferentially metabolized under hypoxia, and glucose can be rapidly converted to fructose via the polyol pathway, the proposed studies will test the hypothesis that fructose metabolism in the intestine results in metabolic reprogramming which switches the host metabolic pathway from mitochondrial β-oxidation to glycolysis and consumes less oxygen. This, in turn, leads to intestinal oxygenation, subsequent inhibiting the growth of obligate anaerobic bacteria and facilitating the expansion of pathogenic bacteria. The hypothesis will be tested in three specific aims: Aim 1. Determine whether fructose induces metabolic reprogramming in intestinal epithelial cells and determine if this results in gut microbiota dysbiosis. We will test the hypothesis that fructose metabolism in the intestine results in metabolic reprogramming and leads to intestinal oxygenation, which in turn, results in gut microbiota dysbiosis. Aim 2. Determine whether modulation of glycolytic activity in intestinal epithelial cells alters gut microbiota composition. We hypothesize that genetic modulation of glycolytic activity via 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase (PFK2) in intestinal epithelial cells results in altered oxygen consumption rate which in turn leads to the alteration of gut microbiota. Aim 3. Determine whether the metabolic effect of fructose in intestine contributes to the development of NAFLD. We will test the hypothesis that the metabolic effects of fructose in intestine on the development of NAFLD is mediated by gut microbiota dysbiosis.
项目标题:果糖在肠道中的代谢作用导致肠道微生物区系失调 抽象的。越来越多的证据表明,肠道微生物区系失调在 肥胖、2型糖尿病和非酒精性脂肪肝的发展。肠道“生理性缺氧”是维持平衡的关键 肠道微生物区系和肠道屏障功能。肠道“生理性缺氧”的紊乱,即氧合,导致 肠道微生物区系失调。我们的初步研究表明,长期喂食果糖或葡萄糖 以类似的方式诱导大鼠和小鼠的肠道微生物区系失调。此外,无论是每日灌胃还是慢性灌胃 HIF-1α报告(ODD-LUC)显示,喂食果糖或葡萄糖会导致肠道氧合 小鼠,而且这种作用在葡萄糖的作用下更加强烈。鉴于果糖在低氧条件下优先代谢, 葡萄糖可以通过多元醇途径快速转化为果糖,拟议的研究将测试 假设肠道中的果糖代谢导致代谢重新编程,从而改变宿主 从线粒体β氧化到糖酵解的代谢途径,消耗更少的氧气。这反过来又导致了 促进肠道氧合,继而抑制专性厌氧菌的生长,促进 病原菌的扩张。这一假设将在三个具体目标中进行检验:目标1.确定 果糖是否诱导肠上皮细胞代谢重编程,并确定这是否会导致 肠道微生物区系失调。我们将检验这样一个假设,即肠道中的果糖代谢导致代谢 重新编程并导致肠道氧合,进而导致肠道微生物区系失调。目标2. 确定肠道上皮细胞糖酵解活性的调节是否改变肠道微生物区系组成。 我们推测,糖酵解活性的遗传调控是通过6-磷酸果糖-2-激酶/果糖-2,6-磷酸-2,6-磷酸。 肠上皮细胞中的二磷酸酶(PFK2)导致氧耗率改变,进而导致 肠道微生物区系的改变。目的3.测定果糖在肠道中的代谢作用 为NAFLD的发展做出了贡献。我们将检验这一假设,即果糖在人体内的代谢作用 肠道对NAFLD的发生发展是由肠道微生物区系失调介导的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ming Song其他文献

Ming Song的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ming Song', 18)}}的其他基金

Project 3 - Ming Song
项目3-鸣歌
  • 批准号:
    10608185
  • 财政年份:
    2016
  • 资助金额:
    $ 21.56万
  • 项目类别:
Project 3 - Ming Song
项目3-鸣歌
  • 批准号:
    10026257
  • 财政年份:
    2016
  • 资助金额:
    $ 21.56万
  • 项目类别:
Dietary Fructose-Induced Metabolic Reprogramming in Intestinal Epithelial Cells Results in Gut Microbiota Dysbiosis
膳食果糖诱导肠上皮细胞代谢重编程导致肠道微生物群失调
  • 批准号:
    10116867
  • 财政年份:
  • 资助金额:
    $ 21.56万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了